Tag: COVID-19

Study: Viral load of COVID-19 patients, deaths declining

Editor's Note This study presented September 24 at the European Society of Clinical Microbiology and Infectious Diseases Conference on Coronavirus Disease finds that the initial SARS-CoV-2 viral load (VL) in nasopharyngeal samples has been decreasing as the pandemic progresses. The researchers from Wayne State University/Detroit Medical Center, Detroit, Michigan, also…

Read More

By: Judy Mathias
September 29, 2020
Share

Administering CPR to PPE-protected healthcare workers during COVID-19

Editor's Note In this Letter to the Editor, physicians from the Department of Anaesthesia and Intensive Care Postgraduate Institute of Medical Education and Research, Chandigarh, India, address the problem of treating a healthcare worker (HCW) who passes out in the OR during a surgical procedure on a COVID-19 patient. The…

Read More

By: Judy Mathias
September 28, 2020
Share

AHA launches new webpage with COVID-19 vaccine resources

Editor's Note The American Hospital Association (AHA) announced September 26 that it has launched a new webpage that comprises AHA-developed tools and resources from the federal government and others related to COVID-19 vaccines. The AHA will update the webpage often as new developments occur to keep the healthcare field informed…

Read More

By: Judy Mathias
September 28, 2020
Share

COVID-19 in healthcare workers

Editor's Note This meta-analysis by researchers in Switzerland and Columbia finds that healthcare workers (HCWs) exhibit a high prevalence of COVID-19 infection, with a significant proportion of them being asymptomatic carriers. This favors silent transmission in clinical and community settings. The meta-analysis comprised 97 studies published in 2020, and 230,398…

Read More

By: Judy Mathias
September 24, 2020
Share

CDC: Changing age distribution of COVID-19

Editor's Note Early in the pandemic, COVID-19 incidence was highest in older adults, but there has been a shift toward younger ages over the summer, this study from the Centers for Disease Control and Prevention (CDC) finds. Nationwide, the median age of COVID-19 patients declined from 46 years in May,…

Read More

By: Judy Mathias
September 24, 2020
Share

Susceptibility of SARS-CoV-2 to UV irradiation

Editor's Note In this study from Germany, researchers found that the SARS-CoV-2 virus is highly susceptible to irradiation with ultraviolet (UV) light. High viral loads (5x106TCID50/mL) were inactivated in 9 minutes with UVC (254 nm) irradiation. The UVC dose required for complete inactivation was 1,048 mJ/cm2. Exposure to UVA (365…

Read More

By: Judy Mathias
September 23, 2020
Share

ECRI: Nearly 70% of N95 masks from China don’t meet US filtration standards

Editor's Note ECRI on September 22 released an analysis showing that 60% to 70% of N95 masks from China do not meet US standards for filtration and effectiveness. ECRI tested nearly 200 masks, reflecting 15 different manufacturer models, which have been purchased by large US healthcare systems. ECRI recommends not…

Read More

By: Judy Mathias
September 23, 2020
Share

Risk factors for COVID-19 transmission in HCWs

Editor's Note In this study from Turkey, researchers investigated the specific risk factors for COVID-19 transmission in healthcare workers (HCWs) in a tertiary care university hospital. Of 703 HCWs tested for COVID-19 during a 60-day period, 50 (7.1%) were positive. Positivity rates were 6.3% for physicians, 8.0% for nurses, 9.1%…

Read More

By: Judy Mathias
September 22, 2020
Share

CDC deletes COVID-19 airborne transmission guidance

Editor's Note The Centers for Disease Control and Prevention (CDC) on September 21 issued a correction to its website, noting that a draft of proposed changes on how COVID-19 spreads, including guidance on airborne transmission, was posted in error on September 18. The CDC is currently updating its recommendations on…

Read More

By: Judy Mathias
September 22, 2020
Share

Efficacy of povidone-iodine nasal antiseptic for rapid inactivation of SARS-CoV-2

Editor's Note This controlled, in-vitro study investigates the minimum contact time for povidone-iodine nasal antiseptic to inactivate the SARS-CoV-2 virus. All laboratory work was conducted in biosafety level 3 laboratories at the Institute for Antiviral Research at Utah State University, Logan. Povidone-iodine was tested at diluted concentrations of 0.5%, 1.25%,…

Read More

By: Judy Mathias
September 21, 2020
Share
Live chat by BoldChat